Strategic ALS Field Liaison - Rare Neurology

Otsuka America Pharmaceutical Inc.; Jackson (MS); Remote; USD 158,000 - 252,000; Full time

Job summary

Otsuka America Pharmaceutical Inc. is seeking a Strategic Account Liaison to drive launch and growth of FUS-ALS in ALS Centers of Excellence and among healthcare providers.

The role emphasizes communicating complex clinical data, patient access, and cross-functional collaboration to advance patient care in rare neurology. The SAL will build relationships with KOLs, navigate treatment logistics, and align with Market Access to remove therapy barriers.

Qualifications

• Experience understanding complex disease states and articulating complex clinical data.
• Educate on disease state awareness, screening and diagnostic pathways.
• Develop and maintain relationships with HCPs and key opinion leaders.
• Explain Otsuka access and patient support programs effectively.
• Present at scientific meetings to educate on rare neurology disease states.

Responsibilities

• Communicate complex clinical data to ALS Centers of Excellence, providers, and stakeholders.
• Drive regional strategy using insights from data sources and market intelligence.
• Navigate site of care, patient onboarding, and therapy initiation barriers.
• Understand hospital purchasing, coding, reimbursement, and access specifics.
• Collaborate with Thought Leads, MSLs, Case Managers, and Leadership to meet customer needs.

Skills

Clinical acumen

Account management

Market development

Collaboration

Training & certification

Education

Bachelor’s Degree

Advanced clinical degrees prioritized

Job description

Otsuka America Pharmaceutical Inc. is seeking a Strategic Account Liaison to drive launch and growth of FUS-ALS in ALS Centers of Excellence and among healthcare providers.

The role emphasizes communicating complex clinical data, patient access, and cross-functional collaboration to advance patient care in rare neurology. The SAL will build relationships with KOLs, navigate treatment logistics, and align with Market Access to remove therapy barriers.